Documente Academic
Documente Profesional
Documente Cultură
W e I g h t l o s s H e a l t h y d I e t E x e r c I s e S c r e e n I n g
P o s t e r V I d e o - t a p e P r o c u r e L e c t u r e
L o w p r e v a l e n c e l e s s c o m p l I c a t I o n
Diabetes Education
The magic capsule for primary and second
W e I g h t DIABETES
l o s s H e aIS
l t hAN
y d IEPEDEMIC
e t E x e r c IDISEASE
s e !S c r e e n I n g
IS IT A PREVENTABLE DISEASE ?
Polyuria ? :
W e I g h t l o s s H e a l t h y d I e t E x e r c I s e S c r e e n I n g
Treat by:
Diet containing a minimum amount of food.
Regulated mode of life. Celsus
diabetes are:
1. Lifestyle
P o s t e rmodification.
V I d e o - t a p e P r o c u r e L e c t u r e
2. Drug use.
Diabetes Pprevention
o s t e r research Vgroup:
I d e o - t a p e P rDiabetes
o c u r e care 23, L e c t u r e
The diabetes prevention program: baseline
characteristics of the randomized cohort 2000
Number 522
Age (mean) 55 years
BMI (mean) 31 kg/m2
Clinical condition IGT
W e I g h t l o s s H e a l t h y d I e t E x e r c I s e S c r e e n I n g
Control group:
Received brief diet and
Exercise counseling
Intervention group:
ReceivedP ointensive
s t e r individualized
V I d e o - t a p e P r o c u r e L e c t u r e
instruction on weight reduction,
Food intake, and guidance on
increasing physical activity
Lifestyle
Duration (mean) L o w
3.2 years p r e v a l e n c e 58% l e s s c o m p l I c a t I o n
Diabetes Prevention Program (DPP)
Number 3,234
Age (mean) 51 years
BMI (mean) 34 kg/m2
Clinical condition IGT
W e I g h t l o s s H e a l t h y d I e t E x e r c I s e S c r e e n I n g
Lifestyle group:
Intensive nutrition and exercise
counseling
Treatment group:
Two masked
P o s t emedications:
r V I d e o - t a p e P r o c u r e L e c t u r e
1. Biguanide Metformin.
2. Placebo. Lifestyle Metformin
Number 235
Age (mean) Younger
BMI (mean) 28 kg/m2
Clinical condition GDM
W e I g h t l o s s H e a l t h y d I e t E x e r c I s e S c r e e n I n g
Placebo group:
Received Placebo
Tested group:
Received Troglitazone which is
Withdrawn
P o s tfrom
e r the groupV I d e o - t a p e P r o c u r e L e c t u r e
Named Thiazolidinediones class Troglitazone
Number 1,429
Age (mean) 55 years
BMI (mean) 31 kg/m2
Clinical condition IGT
W e I g h t l o s s H e a l t h y d I e t E x e r c I s e S c r e e n I n g
Placebo group:
Received Placebo
Tested group: Acarbose
Received Acarbose from the group
named Po-glucosidase
s t e r inhibitor
V I d e o - t a p e
25% P r o c u r e L e c t u r e
To
Duration (mean) 3.3 years
L o w p r e v a l e n c e
36% l e s s c o m p l I c a t I o n
Lifestyle in prevention of type 2 Cumulative probability of remaining free of Diabetes
1
diabetes
0.9
Education pill:
reduce weight >5%.
0.8
Fat <30% of energy consumption.
Fiber intake >15gm per 1000kcal.
Intervention group
Moderate exercise for 30 min/day. 0.7
Control group
then 0.5
W e I g h t One
l o session
s s every
H e athree
l t h ymonths.
d I e t E x e r c I s e 0 1
S c r e 2e n I nStudy
g3 years 4 5 6
Self-reported
Individual guidance on physical
change activity. and exercise Habits during the first year
in dietary
Variable Intervention group Control group
P value
Number 253 (%) Number 247 (%)
Decrease fat consumption P o s t e r 87V I d e o - t a p e 70P r o c u r e L e c t u r e
0.001
Increase vegetables consumption 72 62 0.01
Decrease sugar consumption 55 40
0.001
Increase exercise
Success 36
in achieving the goals 16
of the intervention by one year 0.001
Variable L o w p r e v group
Intervention a l e n c e Control group
l e s s c o m p l I c a t I o n
P value
Number 253 (%) Number 247 (%)
Weight reduction >5% 43 13 0.001
Fat intake <30% 47 26 0.001
Saturated fat intake <10% 26 11 0.001
Fiber intake 15g/1000 kcal 25 12 0.001
Exercise >4 hr/week 86 71 0.001
N Engl J Med,, Vol. 344 May 3, 2001
Public education
Health
HealthEducation
Education
The expected relation between:
W e I g h t l o s s the level
H e a of public
l t h y d I health
e t E x e r c I s e S c r e e n I n g
education and the prevalence of
diabetes. 125 Level of Education
Risk factors:
Controllable vs non-controllable
Risk factors for type 2 Diabetes
Which factors?
Education effect
Pre-diabetes conditions:
Controllable: IGF
IGF ororIGT
IGT Yes
Yes
Weight. P o s t e r VHistory
I d e o - t a p e P r o c u r e L e c t u r e
HistoryofofGDM GDM or or
bigbig
baby
baby> 4> kgm4 kgmYes Yes
Exercise.
Associated disease: Associated conditions:
- Hyperlipidemia Hypertension 140/90 mmHg Yes/No
- Polycystic disease
- Vaculopathy HDL 0.9
HDL 0.9mmol/l
mmol/l triglyceride
triglyceride
2.822.82
mmol/l
mmol/l Yes
Yes
Polycystic
Polycysticovary
ovarydisease
disease(PCOS)
(PCOS) Yes
Yes
L o History
History
w p r e of
v of
avascular
l vascular
e n c e disease
disease l e s s cYes
o m p l I c a Yes
t I o n
Education 21%
21%
A share between doctors and 79%
79%
patient
after training.
47% 53%
47% 53%
Continuity and patient load was
not tested which will affect the L o w p r e v a l e n c e l e s s c o m p l I c a t I o n
out-come.
Doctor Patient
Doctor Patient
After
Aftertraining
training
Therapeutic education
education of
of Patients
Patients Assal,
Assal, 2000
2000
Diabetes Education according to the source
Physicians are the highest in providing patients with diabetes education but they are the
least effective.
The most effective method is the special training classes with >75% effect but not practical.
The role of diabetes educator (nurse) is as effective >75% and more practical.
Others ie; teachers, volunteersetc need to be evaluated.
W e I g h t l o s s H e a l t h y d I e t E x e r c I s e S c r e e n I n g
75 75
75 75
50 50
50 50
L o w p r e v a l e n c e l e s s c o m p l I c a t I o n
25 25
25 25
0 0
0 0
Doctor Diatition Nurse Class Other Doctor Diatition Nurse Class Other
Doctor Diatition Nurse Class Other Doctor Diatition Nurse Class Other
Massachusetts Results from the Behavioral Risk Factor Surveillance System (BRFSS) 1996
Education of physicians vs patients:
401 intervention group focused on improving the skills and knowledge of general
practitioners (EMC).
413 second intervention group focused on patients education and self management (DS).
105 reference group choosing patients from regular clinics (RG).
W e I g h t l o s s H e a l t h y d I e t E x e r c I s e S c r e e n I n g
P o s t e r V I d e o - 0.2
t a p Change
e P r o c(%)
in HbA1c u r e L e c t u r e
0.2 Change in HbA1c (%)
Patient education and self management 0.1
Patient education
decrease HbA1c by and selfcomparing
0.51% management
to the 0.1
decrease HbA1c by 0.51% comparing to the 0
reference group. 0 DS EMC
reference group. -0.1 DS EMC
-0.1
Improving GPs skill and knowledge decrease -0.2
Improving GPs skill and knowledge decrease L -0.2
HbA1c by 0.23% comparing to the reference o w p r e -0.3
v a l e n c e l e s s c o m p l I c a t I o n
HbA1c by 0.23% comparing to the reference
group. -0.3
group. -0.4
-0.4
-0.5
The patient involvement through education in -0.5
The management
their patient involvement through
give extra education
0.28% decreaseinin -0.6
their management give extra 0.28% decrease in -0.6
the mean HbA1c.
the mean HbA1c.
Education
Educationprogram
program
Knowledge
Risk factors
What to do
Reduce weight >5%.
WReduce
e I g h t weight
l o s s >5%. H e a l t h y d I e t E x e r c I s e
Factors:
S c r e e n I n g Weight loss
Age distribution
Fat <30% of energy consumption. Problem size
Healthy diet
Fat <30% of energy consumption. Illiteracy rate
Cultural factor
Health system
Fiber intake >15gm per 1000kcal. Physical activity
Fiber intake >15gm perP1000kcal.
o s t e r
Health beliefs
V I d e o - t a p e P r o c u r e L e c t u r e
L o w p r e v a l e n c e l e s s c o m p l I c a t I o n
Decrease Decrease
costs Prevalence
Model of Diabetes Education
Support group.
Culture
Education
Good
Integrated into level control
Language
lifestyle. P o s t e r Health V I d e o - t a p e P r o c u r e L e c t u r e
Decrease Decrease
medical costs complications
Educology Pharmacology
Definition: Definition:
Using education as a tool for disease Science of drug effect on human body and
prevention or treatment. its role in disease treatment.
Material: Material:
Large verity of methods. Active compound.
W e I g h t l o s s H e a l t h y d I e t E x e r c I s e S c r e e n I n g
Efficacy: Efficacy:
More effective than drugs. Effective according to the dose.
Action: Action:
Long term. Short term.
P o s t e r V I d e o - t a p e P r o c u r e L e c t u r e
Cost: Cost:
50 SR annually.* 4000 SR annually.*
L o w p r e v a l e n c e l e s s c o m p l I c a t I o n
Acceptance: Acceptance:
Less accepted.** More accepted.**
Age:
65 Reference group for age Effective
45-64 0.75 1.21 0.88
W e I g h t 18-44
l o s s H e 0.15
a l t h y d I e t E x 0.96
e r c I s e S c 0.31
r e e n I n g
Sex: Non-effective
Male Reference group for sex
Female 0.75
P o s t e r 0.89
V I d e o - t a p e 1.30
P r o c u r e L e c t u r e
Ethnicity:
White Reference group for race Non-effective
Black 0.95 1.19 1.16
Hispanic 2.14 L o1.30
w p r e v a l e n c e 0.80 l e s s c o m p l I c a t I o n
% Insufficient activity
100
W e I g h t l o s s H e a l t h y d I e t E x e r c I s e S c r e e n I n g
There is no difference
between adults with or 75
without diabetes in the
percentagePof insufficient
71 69
o s t e r V I d e o - t a p e P r o c u r e L e c t u r e
physical activity 50
W e I g h t - Younger
l o s s patients
H e a l have
t h y better
d I e t E x e r c I 25
s e S c r e e n I n31g
education.
- Type of diabetes effect. 13
- The target group 30-65 0
18-30 31-64 >65
Age
P o s t e r V I d e o - t a p e P r o c u r e L e c t u r e
Patient behavior:
15%
37%
How many times did you check your
feet? 31%
L o w p r e v a l e n c e
17% l e s s c o m p l I c a t I o n
None 15%
1-2 times 31%
3-5 times 17%
> 5 times 37%
None 1-2 times 3-5 times > 5 times
W e I g h t l o s s H e a l t h y d I e t E x e r c I s e S c r e e n I n g
P o s t e r V I d e o - t a p e P r o c u r e L e c t u r e
L o w p r e v a l e n c e l e s s c o m p l I c a t I o n
Mass Education